- Nachrichtendetail
-
28.03.2024 13:34:18 - dpa-AFX: *GILEAD : FDA EXPANDS INDICATION FOR VEMLIDY TO TREAT CHRONIC HBV INFECTION IN PEDIATRIC PATIENTS AS YOUNG AS SIX
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
GILEAD SCIENCES DL-,001 | 885823 | Frankfurt | 63,850 | 20.06.24 18:10:48 | +5,010 | +8,51% | 63,800 | 63,830 | 58,470 | 58,840 |
